AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35371278 — intervention group
Group type: COMPARATOR
Intervention: wIRA therapy (Control)
Number of subjects: 120
Study 34551944 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality simulation training combined with skills training
Number of subjects: 120
Study 34551944 — intervention group
Group type: COMPARATOR
Intervention: Conventional training of emergency response
Number of subjects: 120
Study 34551944 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 34896642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical length (CL) ≤30 mm
Number of subjects: 3449
Study 34896642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical length <25 mm
Number of subjects: 3449
Study 34896642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical length between 25 and 30 mm
Number of subjects: 3449
Study 34058682 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline
Number of subjects: 0
Study 34058682 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 0
Study 33163127 — intervention group
Group type: EXPERIMENTAL
Intervention: IV oliceridine
Number of subjects: 2
Study 33163127 — intervention group
Group type: COMPARATOR
Intervention: IV conventional opioids (CO cohort)
Number of subjects: 2
Study 33163127 — intervention group
Group type: EXPERIMENTAL
Intervention: IV oliceridine (high-risk patients)
Number of subjects: 2
Study 33163127 — intervention group
Group type: COMPARATOR
Intervention: IV conventional opioids (high-risk patients)
Number of subjects: 2
Study 35934873 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency umbilical button cannula (EUC) using lateral umbilical cord incision (L-EUC)
Number of subjects: 0
Study 35934873 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency umbilical button cannula (EUC) using standard intersection (S-EUC)
Number of subjects: 0
Study 35934873 — intervention group
Group type: COMPARATOR
Intervention: Umbilical catheter (UC)
Number of subjects: 0
Study 35934873 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency umbilical button cannula (EUC)
Number of subjects: 0
Study 32917473 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) with low-energy flux density (0.05–0.30 mJ/mm2)
Number of subjects: 48
Study 32917473 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 48
Study 32605536 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily questioning
Number of subjects: 141
Study 32605536 — intervention group
Group type: COMPARATOR
Intervention: Fortnightly questioning
Number of subjects: 141
Study 32605536 — intervention group
Group type: COMPARATOR
Intervention: High (3-question) question loads
Number of subjects: 141
Study 32605536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low (1-question) question loads
Number of subjects: 141
Study 32605536 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentivisation
Number of subjects: 141
Study 32605536 — intervention group
Group type: COMPARATOR
Intervention: No financial incentivisation
Number of subjects: 141
Study 35679680 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein diet (CRHP: C30E%-P30E%-F40E%)
Number of subjects: 72
Study 35679680 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes diet (CD: C50E%-P17E%-F33E%)
Number of subjects: 72
Study 35679680 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein diet (CRHP)
Number of subjects: 72
Study 35679680 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes diet (CD)
Number of subjects: 72
Study 33147430 — intervention group
Group type: EXPERIMENTAL
Intervention: Impella usage
Number of subjects: 885
Study 33147430 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ventricular assist devices
Number of subjects: 885
Study 32545147 — intervention group
Group type: EXPERIMENTAL
Intervention: Moringa flour
Number of subjects: 40
Study 32545147 — intervention group
Group type: COMPARATOR
Intervention: Iron group
Number of subjects: 40
Study 34954221 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block (SPGB) with 2% lidocaine prior to anaesthesia induction
Number of subjects: 52
Study 33509762 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive fluid management
Number of subjects: 51
Study 33509762 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluid management
Number of subjects: 51
Study 32839619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac and aortic imaging phenotypes
Number of subjects: 26893
Study 32839619 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaging phenotypes
Number of subjects: 26893
Study 32839619 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-based cardiac and aortic imaging
Number of subjects: 26893
Study 36014837 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU every 4 weeks for 12 weeks)
Number of subjects: 130
Study 32092760 — intervention group
Group type: EXPERIMENTAL
Intervention: rapamycin + ketamine
Number of subjects: 20
Study 32092760 — intervention group
Group type: COMPARATOR
Intervention: placebo + ketamine
Number of subjects: 20
Study 33545548 — intervention group
Group type: EXPERIMENTAL
Intervention: Bufei Yishen formula (BYF) combined with conventional Western medicine
Number of subjects: 134
Study 33545548 — intervention group
Group type: EXPERIMENTAL
Intervention: Key active molecules (KAM) of BYF
Number of subjects: 134
Study 35150086 — intervention group
Group type: EXPERIMENTAL
Intervention: Vivifrail exercise intervention
Number of subjects: 188
Study 35150086 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 188
Study 33966913 — intervention group
Group type: COMPARATOR
Intervention: Buccal chamfer
Number of subjects: 128
Study 33966913 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual chamfer
Number of subjects: 128
Study 33966913 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential chamfer
Number of subjects: 128
Study 32888370 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (15 mg weekly)
Number of subjects: 130
Study 32888370 — intervention group
Group type: COMPARATOR
Intervention: Secukinumab (standard dose)
Number of subjects: 130
Study 36040362 — intervention group
Group type: EXPERIMENTAL
Intervention: 99.9% pure CBD (200 mg/day for 2 weeks, then 300 mg/day for 10 weeks)
Number of subjects: 60
Study 36040362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33545577 — intervention group
Group type: EXPERIMENTAL
Intervention: proG-CSF
Number of subjects: 487
Study 33545577 — intervention group
Group type: EXPERIMENTAL
Intervention: proG-CSF (secondary prophylaxis)
Number of subjects: 487
Study 33545577 — intervention group
Group type: COMPARATOR
Intervention: Control group (no proG-CSF)
Number of subjects: 487
Study 35657375 — intervention group
Group type: EXPERIMENTAL
Intervention: DrugSorb™‐AntiThrombotic Removal (ATR) haemoadsorption device
Number of subjects: 1
Study 35657375 — intervention group
Group type: COMPARATOR
Intervention: Control circuit without the haemoadsorption device
Number of subjects: 1
Study 33441010 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with 1 × 10^6/ml spore suspension of Fusarium redolens
Number of subjects: 3
Study 33441010 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 3
Study 35164986 — intervention group
Group type: EXPERIMENTAL
Intervention: FINLAY-FR-1 (50 µg d-RBD plus outer membrane vesicles from N. meningitidis)
Number of subjects: 60
Study 35164986 — intervention group
Group type: EXPERIMENTAL
Intervention: FINLAY-FR-1A-50 (50 µg d-RBD, three doses)
Number of subjects: 60
Study 35164986 — intervention group
Group type: EXPERIMENTAL
Intervention: FINLAY-FR-1A-25 (25 µg d-RDB, three doses)
Number of subjects: 60
Study 35164986 — intervention group
Group type: COMPARATOR
Intervention: FINLAY-FR-1 (homologous schedule)
Number of subjects: 60
Study 35164986 — intervention group
Group type: COMPARATOR
Intervention: FINLAY-FR-1 (heterologous schedule)
Number of subjects: 60
Study 34159704 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous concentrated growth factors (CGF)
Number of subjects: 50
Study 34159704 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 50
Study 32538747 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid parenteral nutrition
Number of subjects: 80
Study 32538747 — intervention group
Group type: COMPARATOR
Intervention: Control group (equal-nitrogen and equal-calorie enteral and parenteral nutrition)
Number of subjects: 80
Study 32538747 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 34022926 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support (n = 10 units)
Number of subjects: 30
Study 34022926 — intervention group
Group type: COMPARATOR
Intervention: Lean implementation (n = 10 units)
Number of subjects: 30
Study 34022926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustainability (n = 10 units)
Number of subjects: 30
Study 32504178 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps tendon–patellar bone (QTB) autograft
Number of subjects: 60
Study 32504178 — intervention group
Group type: COMPARATOR
Intervention: Bone–patellar tendon–bone (BPTB) autograft
Number of subjects: 60
Study 616606737 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval aerobic training (12 weeks, treadmill running at 50-80% heart rate reserve, 3 times a week, duration increased from 12 to 36 minutes)
Number of subjects: 36
Study 616606737 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study 34358534 — intervention group
Group type: EXPERIMENTAL
Intervention: ANN-assisted model based on CT radiomics of primary tumors
Number of subjects: 313
Study 34358534 — intervention group
Group type: COMPARATOR
Intervention: Traditional LN evaluation
Number of subjects: 313
Study 32280092 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg supplementation
Number of subjects: 250
Study 36120764 — intervention group
Group type: EXPERIMENTAL
Intervention: TE + INIT
Number of subjects: 80
Study 36120764 — intervention group
Group type: EXPERIMENTAL
Intervention: TE + SM
Number of subjects: 80
Study 36120764 — intervention group
Group type: COMPARATOR
Intervention: TE
Number of subjects: 80
Study 33348306 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology for 20 minutes, done for three consecutive days.
Number of subjects: 90
Study 33348306 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 20 minutes, done for three consecutive days.
Number of subjects: 90
Study 33348306 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 90
Study 32825555 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive physical-cognitive game-based training, 1 hour session, 3 times a week for 12 weeks
Number of subjects: 40
Study 35421086 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning bright light therapy (10,000 lux at the eye) for 60 minutes every morning for 4 weeks
Number of subjects: 33
Study 35421086 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning bright light therapy
Number of subjects: 33
Study 34167430 — intervention group
Group type: EXPERIMENTAL
Intervention: incomplete radiofrequency ablation (iRFA)
Number of subjects: 0
Study 33144269 — intervention group
Group type: EXPERIMENTAL
Intervention: QPS5
Number of subjects: 46
Study 33144269 — intervention group
Group type: COMPARATOR
Intervention: cTBS
Number of subjects: 46
Study 33144269 — intervention group
Group type: EXPERIMENTAL
Intervention: QPS
Number of subjects: 46
Study 33144269 — intervention group
Group type: COMPARATOR
Intervention: TBS
Number of subjects: 46
Study 33030412 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min bout of cycling at 50% to 60% of maximal power output
Number of subjects: 20
Study 33030412 — intervention group
Group type: COMPARATOR
Intervention: Watching a neutral film
Number of subjects: 20
Study 34086695 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolphins image condition
Number of subjects: 20944
Study 34086695 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocean wildlife image condition
Number of subjects: 20944
Study 34086695 — intervention group
Group type: EXPERIMENTAL
Intervention: Children image condition
Number of subjects: 20944
Study 34086695 — intervention group
Group type: EXPERIMENTAL
Intervention: People staring out image condition
Number of subjects: 20944
Study 35183882 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of boron citrate twice a day
Number of subjects: 40
Study 35183882 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of oleoylethanolamide twice a day
Number of subjects: 40
Study 35183882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies (5 mg of boron citrate and 200 mg of oleoylethanolamide)
Number of subjects: 40
Study 35183882 — intervention group
Group type: COMPARATOR
Intervention: Routine treatments without any study medications (Control)
Number of subjects: 40
Study 34059428 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram advertisements (Traffic campaign + Feed ad placement)
Number of subjects: 80
Study 34059428 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram advertisements (other strategies)
Number of subjects: 80
Study 34059428 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 35781459 — intervention group
Group type: EXPERIMENTAL
Intervention: Anifrolumab (Saphnelo®) administered as an intravenous infusion, 300 mg over a 30-minute period, every 4 weeks
Number of subjects: 0
Study 32377783 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g TXA (intravenous)
Number of subjects: 200
Study 32377783 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g TXA (topical)
Number of subjects: 200
Study 32377783 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g TXA (combined intravenous + topical)
Number of subjects: 200
Study 32377783 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g TXA (combined + group)
Number of subjects: 200
Study 32377783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 35610659 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 80
Study 35610659 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 80
Study 35610659 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 80
Study 35610659 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 80
Study 34781799 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-sale communication campaign for cigarillos
Number of subjects: 1976
Study 34781799 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-sale communication campaign for waterpipe tobacco
Number of subjects: 1976
Study 34781799 — intervention group
Group type: COMPARATOR
Intervention: No message control condition for cigarillos
Number of subjects: 1976
Study 34781799 — intervention group
Group type: COMPARATOR
Intervention: No message control condition for waterpipe tobacco
Number of subjects: 1976
Study 33148266 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Literacy (HL)
Number of subjects: 192
Study 33148266 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care behaviors
Number of subjects: 192
Study 33148266 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Literacy and Self-care behaviors combined with demographic variables
Number of subjects: 192
Study 34137514 — intervention group
Group type: EXPERIMENTAL
Intervention: Aomei meloxicam (15 mg)
Number of subjects: 48
Study 34137514 — intervention group
Group type: COMPARATOR
Intervention: Mobic meloxicam (15 mg)
Number of subjects: 48
Study 33103469 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic surgery (Roux‐en‐Y gastric bypass and sleeve gastrectomy)
Number of subjects: 566
Study 33103469 — intervention group
Group type: COMPARATOR
Intervention: Control group (no metabolic surgery)
Number of subjects: 566
Study 37436823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial HWLs on the tobacco package
Number of subjects: 403
Study 37436823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial HWLs on all waterpipe's parts
Number of subjects: 403
Study 37436823 — intervention group
Group type: COMPARATOR
Intervention: Text-only HWL on the tobacco package
Number of subjects: 403
Study 33719920 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 20 min)
Number of subjects: 31
Study 33719920 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 31
Study 33001144 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 304
Study 35607946 — intervention group
Group type: EXPERIMENTAL
Intervention: γ‐tACS (transcranial alternating current stimulation at gamma-frequency)
Number of subjects: 60
Study 35607946 — intervention group
Group type: COMPARATOR
Intervention: sham tACS
Number of subjects: 60
Study 32700572 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate initiation of lipid lowering (treatment for 30 years) in 40- to 49-year-old patients with non-HDL-C ≥160 mg/dL
Number of subjects: 3148
Study 32700572 — intervention group
Group type: EXPERIMENTAL
Intervention: Delaying lipid lowering by 10 years (treatment for 20 years)
Number of subjects: 3148
Study 32700572 — intervention group
Group type: EXPERIMENTAL
Intervention: Delaying lipid lowering by 20 years (treatment for 10 years)
Number of subjects: 3148
Study 35733202 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral motor priming and task-specific training (30 hours total over 5 weeks)
Number of subjects: 76
Study 35733202 — intervention group
Group type: COMPARATOR
Intervention: Control priming (transcutaneous electrical stimulation) plus task-specific training (30 hours total over 5 weeks)
Number of subjects: 76
Study 34094511 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-protein nut-based (HP-NB) snack
Number of subjects: 10
Study 34094511 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-protein nut-based (HP-NB) snack + white bread (WB)
Number of subjects: 10
Study 34094511 — intervention group
Group type: COMPARATOR
Intervention: Higher-carbohydrate (CHO) cereal-based bar (HC-CB)
Number of subjects: 10
Study 32344499 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 203
Study 32344499 — intervention group
Group type: COMPARATOR
Intervention: Cu-IUDs
Number of subjects: 203
Study 35704027 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2 g/day CLA
Number of subjects: 65
Study 35704027 — intervention group
Group type: COMPARATOR
Intervention: 3.2 g/day sunflower oil (placebo)
Number of subjects: 65
Study 33106482 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral analysis technique for resolving time dependence in quantum processors
Number of subjects: 0
Study 33106482 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized benchmarking, gate set tomography, and Ramsey spectroscopy
Number of subjects: 0
Study 32456704 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based Neonatal Resuscitation Game (Gamers)
Number of subjects: 162
Study 32456704 — intervention group
Group type: EXPERIMENTAL
Intervention: Players (Gamers who utilized the game)
Number of subjects: 162
Study 32456704 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-players (Gamers who did not utilize the game)
Number of subjects: 162
Study 32456704 — intervention group
Group type: COMPARATOR
Intervention: Control group (Controls with no access to the game)
Number of subjects: 162
Study 32859542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent diet
Number of subjects: 60
Study 32859542 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus physical therapy
Number of subjects: 60
Study 32859542 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 60
Study 32996629 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined Cue Utilization and Engagement in Dementia (CUED) mealtime video-coding scheme
Number of subjects: 110
Study 35440469 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (500 µg daily for 14 days)
Number of subjects: 2755
Study 35440469 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2755
Study 35440469 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 2755
Study 34285701 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberis integerrima fruit extract (1000 mg daily, 5 ml twice daily)
Number of subjects: 65
Study 34285701 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment with metformin only)
Number of subjects: 65
Study 34227113 — intervention group
Group type: EXPERIMENTAL
Intervention: Thula Sana intervention
Number of subjects: 333
Study 33773697 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched bread with 0.05% of a 1:1 mixture of (‐)‐epicatechin and quercetin
Number of subjects: 156
Study 33721505 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional bolus cement technique
Number of subjects: 18
Study 33721505 — intervention group
Group type: COMPARATOR
Intervention: Swirl cement technique
Number of subjects: 18
Study 34450101 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention (protocol dissemination, education for healthcare professionals and patients, feedback on performance) for 12 months
Number of subjects: 4478
Study 34450101 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 4478
Study 32731928 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 1135
Study 32731928 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 1135
Study 33804259 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein dairy milk + resistance training (MR)
Number of subjects: 30
Study 33804259 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate + resistance training (PR)
Number of subjects: 30
Study 33032644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pessary self-management teaching, self-management information leaflet, follow-up phone call, access to local telephone support.
Number of subjects: 0
Study 33032644 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based pessary care (standard at their centre).
Number of subjects: 0
Study 37076838 — intervention group
Group type: EXPERIMENTAL
Intervention: depression education fotonovela
Number of subjects: 0
Study 37076838 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0